Someday, it may be possible to take just one pill a week for conditions as varied as Alzheimer’s, addiction, allergies, malaria, schizophrenia, high cholesterol, and HIV.
That was Lyndra’s pitch, anyway. Now, the Watertown, Mass.-based biotech is promoting its first set of clinical data to back up those promises.
About the Author Reprints
